Zydus Lifesciences Ltd
General
Total Cases1
Active Cases1
Patents--
Ratings
Experience
Grade
Trend
DCT
L4
E
PTAB
--
--
--
CAFC
L4
B
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
---|---|---|
02/19/25 | Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nms) (Entered: 02/19/2025) | |
02/18/25 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by ACADIA Pharmaceuticals Inc. (jfm) (Entered: 02/18/2025) | |
02/18/25 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,601,740; 7,659,285; 7,732,615; 10,517,860; 10,953,000. (jfm) (Entered: 02/18/2025) | |
02/18/25 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 01/03/2025. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 7/3/2027. (jfm) (Entered: 02/18/2025) | |
02/18/25 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 02/18/2025) | |
02/18/25 | No Summons Issued. (jfm) (Entered: 02/18/2025) | |
02/18/25 | COMPLAINT against Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC (Filing fee $ 405, receipt number ADEDC-4615434) - filed by ACADIA Pharmaceuticals Inc. (Attachments: # [1] Exhibits A-E, # [2] Civil Cover Sheet)(jfm) (Entered: 02/18/2025) |